Meet Dr. Takahiro Shibata – winner of the 2024 STEM CELLS Translational Medicine Early Career Investigator Award and his award-winning paper Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
Latest articles
Patients suffering from microtia have limited treatment options for auricular reconstruction due to donor-site morbidity, complications, and unaesthetic outcome. Therefore, tissue engineering emerged as an alternative therapeutic option. Here, we generated and characterized human auricular ...
Background Mesenchymal stem cells (MSCs) require priming by proinflammatory stimuli for optimal immunosuppressive effects. Our previous work identified mixed lymphocyte reaction-conditioned medium (MLR-CdM) as a potent enhancer of MSC immunosuppressive properties. This study evaluates the ...
Glucocorticoid-induced osteoporosis (GIOP), the most common cause of secondary osteoporosis, is characterized by significant bone loss, decreased bone quality, and increased fracture risk. The current treatments for GIOP have several drawbacks. Exosomes are vital for cellular processes. However, ...
Peripheral nerve injury remains an intractable clinical issue with high morbidity, causing an excessive burden on the economy and society. Peripheral nerve tissue engineering combined with nerve conduits and supporting seed cells is considered a promising strategy for treating of long nerve ...
Background Bladder dysfunction may occur with high frequency in postmenopausal women with metabolic syndrome (MetS). This study evaluated the therapeutic effects of human amniotic fluid stem cells (hAFSCs) on bladder dysfunction in ovariectomized rats with MetS. Materials and Methods Forty-eight ...
The rapidly developing field of renal spheroids and organoids has emerged as a valuable tool for modeling nephrotoxicity, kidney disorders, and kidney development. However, existing studies have relied on intricate and sophisticated differentiation protocols to generate organoids and tubuloids, ...
Most read
The use of dental implants to replace lost or damaged teeth has become increasingly widespread due to their reported high survival and success rates. In reality, the long-term survival of dental implants remains a health concern, based on their short-term predicted survival of ~15 years, significant potential for jawbone ...
Research conducted on the International Space Station (ISS) in low-Earth orbit (LEO) has shown the effects of microgravity on multiple organs. To investigate the effects of microgravity on the central nervous system, we developed a unique organoid strategy for modeling specific regions of the brain that are affected by ...
Glucocorticoid-induced osteoporosis (GIOP), the most common cause of secondary osteoporosis, is characterized by significant bone loss, decreased bone quality, and increased fracture risk. The current treatments for GIOP have several drawbacks. Exosomes are vital for cellular processes. However, very few studies have ...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which multiple organs are damaged by the immune system. Although standard treatment options such as hydroxychloroquine (HCQ), glucocorticoids (GCs), and other immunosuppressive or immune-modulating agents can help to manage symptoms, they do not offer a ...
Peripheral nerve injury remains an intractable clinical issue with high morbidity, causing an excessive burden on the economy and society. Peripheral nerve tissue engineering combined with nerve conduits and supporting seed cells is considered a promising strategy for treating of long nerve defects. However, supporting ...
The ultimate goal of cardiac tissue engineering is to generate new muscle to repair or replace the damaged heart. This requires advances in stem cell technologies to differentiate billions of cardiomyocytes, together with advanced biofabrication approaches such as 3D bioprinting to achieve the requisite structure and ...
Editor-in-Chief
Anthony Atala
Impact Factor
5.4
5 year Impact Factor
6.1
CiteScore
13.1
Call for Papers
STEM CELLS Translational Medicine is currently seeking submissions on human clinical articles and cord blood. Visit our Call for Papers to learn more and submit your research for an upcoming issue.
Learn more
High-Impact Research Collection
Explore the most cited, most read, and most discussed articles published in STEM CELLS Translational Medicine in recent years and discover what has caught the interest of your peers.
Browse the collection here
The perfect home for your research
With benefits including a simple submission process, rapid publication, and high ranking, STEM CELLS Translational Medicine is the perfect home for your research. As of May 1st 2025, the journal no longer charges submission fees.
Learn more about publishing with us here.
Early Career Investigator Award
STEM CELLS Translational Medicine's Early Career Investigator Award gives promising early career scientists the chance to gain beneficial recognition and promotion of their impactful research. Learn more about the award and discover past recipients and their papers.
Read now
Sister Journal: STEM CELLS
STEM CELLS focuses primarily on the functional and mechanistic aspects of stem cell biology and the potential of different types of stem cells for therapeutic applications.
Learn more
Email alerts
Register to receive table of contents email alerts as soon as new issues of Stem Cells Translational Medicine are published online.
Sign up
Author resources
Learn about how to submit your article, our publishing process, and tips on how to promote your article.
Find out more
Become a reviewer for STEM CELLS Translational Medicine
STEM CELLS Translational Medicine would like to invite you to review for the journal. Please consider joining us as an ad hoc peer reviewer, where you will be periodically invited to review manuscripts based on your area of expertise.
Learn more about becoming a reviewer
Committee on Publication Ethics (COPE)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE)
publicationethics.org
Read and Publish deals
Authors interested in publishing in STEM CELLS Translational Medicine may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP.
Find out if your institution is participating
Recommend to your library
Fill out our simple online form to recommend STEM CELLS Translational Medicine to your library.
Recommend now
Cord Blood Association
STEM CELLS Translational Medicine is the official scientific journal of the Cord Blood Association.
